litlas
Log inCreate account

William W. Hauswirth

Active 1971–2023

144
Papers
26,248
Citations
96
h-index
143
i10-index

Citations

Citations per year for William W. Hauswirth1975: 1 citations1976: 1 citations1978: 1 citations1979: 4 citations1980: 7 citations1981: 5 citations1982: 5 citations1983: 14 citations1984: 22 citations1985: 26 citations1986: 19 citations1987: 26 citations1988: 21 citations1989: 26 citations1990: 27 citations1991: 31 citations1992: 22 citations1993: 29 citations1994: 30 citations1995: 22 citations1996: 42 citations1997: 67 citations1998: 61 citations1999: 88 citations2000: 73 citations2001: 85 citations2002: 93 citations2003: 120 citations2004: 143 citations2005: 168 citations2006: 243 citations2007: 199 citations2008: 206 citations2009: 247 citations2010: 338 citations2011: 295 citations2012: 324 citations2013: 383 citations2014: 329 citations2015: 348 citations2016: 302 citations2017: 332 citations2018: 276 citations2019: 733 citations2020: 866 citations2021: 771 citations2022: 554 citations2023: 415 citations2024: 521 citations2025: 228 citations2026: 1 citations1977: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,097 citing papers, 40.2% of this breakdownUnited Kingdom: 593 citing papers, 7.7% of this breakdownChina: 461 citing papers, 6% of this breakdownGermany: 453 citing papers, 5.9% of this breakdownFrance: 345 citing papers, 4.5% of this breakdownItaly: 266 citing papers, 3.4% of this breakdownCanada: 258 citing papers, 3.3% of this breakdownJapan: 224 citing papers, 2.9% of this breakdownAustralia: 193 citing papers, 2.5% of this breakdownNetherlands: 155 citing papers, 2% of this breakdownSpain: 151 citing papers, 2% of this breakdownSwitzerland: 148 citing papers, 1.9% of this breakdown
0%40.2%Other 17.7%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology64.1%
  • Medicine18.7%
  • Neuroscience12.2%
  • Immunology and Microbiology1.3%
  • Agricultural and Biological Sciences1.1%
  • Engineering0.6%
  • Other2%

Topics

  • Retinal Development and Disorders11.4%
  • Retinal Diseases and Treatments6.1%
  • Virus-based gene therapy research6%
  • Mitochondrial Function and Pathology4.1%
  • CRISPR and Genetic Engineering3.9%
  • Photoreceptor and optogenetics research2.6%
  • Other65.9%

Coauthors

All papers

Open in search
  1. Dual AAV-mediated gene therapy restores hearing in a DFNB9 mouse model

    Authors: Omar Akil, Frank M. Dyka, Charlotte Calvet, Alice Emptoz, Ghizlène Lahlou, Sylvie Nouaille, Jacques Boutet de Monvel, Jean‐Pierre Hardelin, William W. Hauswirth, Paul Avan, Christine Petit, Saaïd Safieddine, Lawrence R. Lustig - National Academy of Sciences, Proceedings of the National Academy of Sciences 2019 cited by 294

  2. DICER1 Loss and Alu RNA Induce Age-Related Macular Degeneration via the NLRP3 Inflammasome and MyD88

    Authors: Valeria Tarallo, Yoshio Hirano, Bradley D. Gelfand, Sami Dridi, Nagaraj Kerur, Young‐Hee Kim, Won Gil Cho, Hiroki Kaneko, Benjamin J. Fowler, Sasha Bogdanovich, Romulo Albuquerque, William W. Hauswirth, Vince A. Chiodo, Jennifer F. Kugel, James A. Goodrich, Steven L. Ponicsan, Gautam Chaudhuri, Michael P. Murphy, Joshua L. Dunaief, Balamurali K. Ambati, Yuichiro Ogura, Jae Wook Yoo, Dong Ki Lee, Patrick Provost, David R. Hinton, Gabriel Núñez, Judit Baffi, Mark E. Kleinman, Jayakrishna Ambati - Cell 2012 cited by 600

  3. Treatment of Leber Congenital Amaurosis Due to RPE65 Mutations by Ocular Subretinal Injection of Adeno-Associated Virus Gene Vector: Short-Term Results of a Phase I Trial

    Authors: William W. Hauswirth, Tomás S. Alemán, Shalesh Kaushal, Artur V. Cideciyan, Sharon Schwartz, Lili Wang, Thomas J. Conlon, Sanford L. Boye, Terence R. Flotte, Barry J. Byrne, Samuel G. Jacobson - Human Gene Therapy 2008 cited by 947

  4. DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration

    Authors: Hiroki Kaneko, Sami Dridi, Valeria Tarallo, Bradley D. Gelfand, Benjamin J. Fowler, Won Gil Cho, Mark E. Kleinman, Steven L. Ponicsan, William W. Hauswirth, Vince A. Chiodo, Katalin Karikó, Jae Wook Yoo, Dong-ki Lee, Majda Hadziahmetovic, Ying Song, Smita Misra, Gautam Chaudhuri, F. William Buaas, Robert E. Braun, David R. Hinton, Qing Zhang, Hans E. Grossniklaus, Jan Provis, Michele C. Madigan, Ann H. Milam, Nikki L. Justice, Romulo Albuquerque, Alexander D. Blandford, Sasha Bogdanovich, Yoshio Hirano, Jassir Witta, Elaine Fuchs, Dan R. Littman, Balamurali K. Ambati, Charles M. Rudin, Mark M. W. Chong, Patrick Provost, Jennifer F. Kugel, James A. Goodrich, Joshua L. Dunaief, Judit Baffi, Jayakrishna Ambati - Nature 2011 cited by 619

  5. A Muscleblind Knockout Model for Myotonic Dystrophy

    Authors: Rahul Kanadia, Karen A. Johnstone, Ami Mankodi, Codrin Lungu, Charles A. Thornton, Douglas W Esson, Adrian M. Timmers, William W. Hauswirth, Maurice S. Swanson - Science 2003 cited by 750

  6. Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phase I trial

    Authors: Nicola G. Ghazi, Emad B. Abboud, Sawsan R. Nowilaty, Hisham Alkuraya, Abdulrahman Alhommadi, Huimin Cai, Rui Hou, Wen‐Tao Deng, Sanford L. Boye, Abdulrahman Almaghamsi, Fahad Al Saikhan, Hassan Al-Dhibi, David G. Birch, Christopher Chung, Dilek Çolak, Matthew M. LaVail, Douglas Vollrath, Kirsten Erger, Wen‐qiu Wang, Thomas J. Conlon, Kang Zhang, William W. Hauswirth, Fowzan S. Alkuraya - Human Genetics 2016 cited by 240

  7. Novel Properties of Tyrosine-mutant AAV2 Vectors in the Mouse Retina

    Authors: Hilda Petrs‐Silva, Astra Dinculescu, Qiuhong Li, Wen‐Tao Deng, Jijing Pang, Seok-Hong Min, Vince A. Chiodo, Andy W. Neeley, L. Govindasamy, Antonette Bennett, Mavis Agbandje‐McKenna, Zhong Li, Baozheng Li, Giridhara R. Jayandharan, Arun Srivastava, Alfred S. Lewin, William W. Hauswirth - Molecular Therapy 2010 cited by 265

  8. Functional genomic screening identifies dual leucine zipper kinase as a key mediator of retinal ganglion cell death

    Authors: Derek S. Welsbie, Zhiyong Yang, Yan Ge, Katherine L. Mitchell, Xinrong Zhou, Scott E. Martin, Cynthia Berlinicke, László Hackler, John A. Fuller, Jie Fu, Li-Hui Cao, Bing Han, Douglas S. Auld, Tian Xue, Syu-ichi Hirai, Lucie Germain, Caroline Simard-Bisson, Richard Blouin, Judy V. Nguyen, Chung-ha O. Davis, Ray A. Enke, Sanford L. Boye, Shannath L. Merbs, Nicholas Marsh‐Armstrong, William W. Hauswirth, Aaron DiAntonio, Robert W. Nickells, James Inglese, Justin Hanes, King‐Wai Yau, Harry A. Quigley, Donald J. Zack - National Academy of Sciences, Proceedings of the National Academy of Sciences 2013 cited by 271

  9. Gene Therapy for Leber Hereditary Optic Neuropathy

    Authors: John Guy, William J. Feuer, Janet L. Davis, Vittorio Porciatti, Phillip Gonzalez, Rajeshwari D. Koilkonda, Huijun Yuan, William W. Hauswirth, Byron L. Lam - Ophthalmology 2017 cited by 201

  10. Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement

    Authors: Artur V. Cideciyan, Samuel G. Jacobson, William A. Beltran, Alexander Sumaroka, Małgorzata Świder, Simone Iwabe, Alejandro J. Román, Melani B. Olivares, Sharon Schwartz, András M. Komáromy, William W. Hauswirth, Gustavo D. Aguirre - National Academy of Sciences, Proceedings of the National Academy of Sciences 2013 cited by 440

  11. Dual ABCA4 -AAV Vector Treatment Reduces Pathogenic Retinal A2E Accumulation in a Mouse Model of Autosomal Recessive Stargardt Disease

    Authors: Frank M. Dyka, Laurie L. Molday, Vince A. Chiodo, Robert S. Molday, William W. Hauswirth - Human Gene Therapy 2019 cited by 58

  12. Improvement and Decline in Vision with Gene Therapy in Childhood Blindness

    Authors: Samuel G. Jacobson, Artur V. Cideciyan, Alejandro J. Román, Alexander Sumaroka, Sharon Schwartz, Elise Héon, William W. Hauswirth - New England Journal of Medicine 2015 cited by 377

  13. A Comprehensive Review of Retinal Gene Therapy

    Authors: Sanford L. Boye, Sanford L. Boye, Alfred S. Lewin, William W. Hauswirth - Molecular Therapy 2013 cited by 262

  14. SOD2 Knockdown Mouse Model of Early AMD

    Authors: Verline Justilien, Jijing Pang, Kutralanathan Renganathan, Xianquan Zhan, John W. Crabb, So Ra Kim, Janet R. Sparrow, William W. Hauswirth, Alfred S. Lewin - Investigative Ophthalmology & Visual Science 2007 cited by 236

  15. Effect of CNTF on Retinal Ganglion Cell Survival in Experimental Glaucoma

    Authors: Mary Ellen Pease, Donald J. Zack, Cynthia Berlinicke, Kristen Bloom, Frances E. Cone, Yuxia Wang, Ronald L. Klein, William W. Hauswirth, Harry A. Quigley - Investigative Ophthalmology & Visual Science 2009 cited by 223

  16. Gene therapy restores vision in a canine model of childhood blindness

    Authors: Gregory M. Acland, Geoffrey K. Aguirre, Jharna Ray, Qí Zhāng, Tomás S. Alemán, Artur V. Cideciyan, Susan E. Pearce-Kelling, Vibha Anand, Yong Zeng, Albert M. Maguire, Samuel G. Jacobson, William W. Hauswirth, Jean Bennett - Nature Genetics 2001 cited by 1,195

  17. High-efficiency Transduction of the Mouse Retina by Tyrosine-mutant AAV Serotype Vectors

    Authors: Hilda Petrs‐Silva, Astra Dinculescu, Qiuhong Li, Seok-Hong Min, Vince A. Chiodo, Jijing Pang, Zhong Li, Sergei Zolotukhin, Arun Srivastava, Alfred S. Lewin, William W. Hauswirth - Molecular Therapy 2008 cited by 394

  18. Virally delivered Channelrhodopsin-2 Safely and Effectively Restores Visual Function in Multiple Mouse Models of Blindness

    Authors: M. Mehdi Doroudchi, Kenneth P. Greenberg, Jianwen Liu, Kimberly A Silka, Edward S. Boyden, Jennifer A. Lockridge, A. Cyrus Arman, Janani Ramesh, Sanford L. Boye, Sanford L. Boye, Gabriel M. Gordon, Benjamin C Matteo, Alapakkam P. Sampath, William W. Hauswirth, Alan Horsager - Molecular Therapy 2011 cited by 277

  19. Results at 2 Years after Gene Therapy for RPE65-Deficient Leber Congenital Amaurosis and Severe Early-Childhood–Onset Retinal Dystrophy

    Authors: Richard G. Weleber, Mark E. Pennesi, David J. Wilson, Shalesh Kaushal, Laura Erker, Lauren Jensen, Maureen T. McBride, Terence R. Flotte, Margaret Humphries, Roberto Calcedo, William W. Hauswirth, Jeffrey D. Chulay, J. Timothy Stout - Ophthalmology 2016 cited by 218

  20. Gene delivery to mitochondria by targeting modified adenoassociated virus suppresses Leber’s hereditary optic neuropathy in a mouse model

    Authors: Hong Yu, Rajeshwari D. Koilkonda, Tsung-Han Chou, Vittorio Porciatti, Sacide S. Ozdemir, Vince A. Chiodo, Sanford L. Boye, Sanford L. Boye, William W. Hauswirth, Alfred S. Lewin, John Guy - National Academy of Sciences, Proceedings of the National Academy of Sciences 2012 cited by 190

  21. Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential.

    Authors: Qiuhong Li, Rehae Miller, Pingyang Han, Jijing Pang, Astra Dinculescu, Vince A. Chiodo, William W. Hauswirth - 2008 cited by 188

  22. Dual Adeno-Associated Virus Vectors Result in Efficient In Vitro and In Vivo Expression of an Oversized Gene, MYO7A

    Authors: Frank M. Dyka, Sanford L. Boye, Vince A. Chiodo, William W. Hauswirth, Sanford L. Boye - Human Gene Therapy Methods 2014 cited by 127

  23. Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics

    Authors: Artur V. Cideciyan, Tomás S. Alemán, Sanford L. Boye, Sharon Schwartz, Shalesh Kaushal, Alejandro J. Román, Jijing Pang, Alexander Sumaroka, Elizabeth A. M. Windsor, James M. Wilson, Terence R. Flotte, Gerald A. Fishman, Elise Héon, Edwin M. Stone, Barry J. Byrne, Samuel G. Jacobson, William W. Hauswirth - National Academy of Sciences, Proceedings of the National Academy of Sciences 2008 cited by 664

  24. Gene Therapy with Brain-Derived Neurotrophic Factor As a Protection: Retinal Ganglion Cells in a Rat Glaucoma Model

    Authors: Keith R. Martin, Harry A. Quigley, Donald J. Zack, Hana Levkovitch-Verbin, Jennifer L. Kielczewski, Danielle Valenta, Lisa A. Baumrind, Mary Ellen Pease, Ronald L. Klein, William W. Hauswirth - Investigative Ophthalmology & Visual Science 2003 cited by 363